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Abstract
Streptococcus pneumoniae is an important cause of otitis media and invasive disease. Since introduction of the heptavalent
pneumococcal conjugate vaccine, there has been an increase in replacement disease due to serotype 19A clonal complex
(CC)199 isolates. The goals of this study were to 1) describe genetic diversity among nineteen CC199 isolates from carriage,
middle ear, blood, and cerebrospinal fluid, 2) compare CC199 19A (n=3) and 15B/C (n=2) isolates in the chinchilla model
for pneumococcal disease, and 3) identify accessory genes associated with tissue-specific disease among a larger collection
of S. pneumoniae isolates. CC199 isolates were analyzed by comparative genome hybridization. One hundred and twenty-
seven genes were variably present. The CC199 phylogeny split into two main clades, one comprised predominantly of
carriage isolates and another of disease isolates. Ability to colonize and cause disease did not differ by serotype in the
chinchilla model. However, isolates from the disease clade were associated with faster time to bacteremia compared to
carriage clade isolates. One 19A isolate exhibited hypervirulence. Twelve tissue-specific genes/regions were identified by
correspondence analysis. After screening a diverse collection of 326 isolates, spr0282 was associated with carriage. Four
genes/regions, SP0163, SP0463, SPN05002 and RD8a were associated with middle ear isolates. SPN05002 also associated
with blood and CSF, while RD8a associated with blood isolates. The hypervirulent isolate’s genome was sequenced using
the Solexa paired-end sequencing platform and compared to that of a reference serotype 19A isolate, revealing the
presence of a novel 20 kb region with sequence similarity to bacteriophage genes. Genetic factors other than serotype may
modulate virulence potential in CC199. These studies have implications for the long-term effectiveness of conjugate
vaccines. Ideally, future vaccines would target common proteins to effectively reduce carriage and disease in the vaccinated
population.
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Introduction
Streptococcus pneumoniae asymptomatically colonizes the upper
respiratory tract of approximately half of all healthy children and
is a leading cause of acute otitis media, pneumonia and meningitis
globally [1]–[3]. Although our comprehension of the epidemiol-
ogy, pathogenesis, and virulence factors of S. pneumoniae has
improved in recent years, the basis for whether colonization with a
specific strain establishes asymptomatic colonization or produces
local or invasive diseases requires further elucidation.
Encapsulated strains of S. pneumoniae express one of at least 93
distinct capsular polysaccharides [4], [5]. Since the introduction of
the heptavalent pneumococcal conjugate vaccine (PCV7; sero-
types 4, 6B, 9V, 14, 18C, 19F and 23F) in 2000, a large overall
decrease in invasive disease continues to be observed [6], [7].
However, non-vaccine serotypes have increased in prevalence [8]–
[11]. Studies show a significant increase in the number of otitis
media and invasive disease cases due to serotype 19A [8], [12]–
[14]. In the United States and Europe, clonal complex (CC)199
was a major clonal lineage throughout the period of expansion of
serotype 19A [9], [14]–[17]. A small percentage of these CC199
19A isolates are associated with antimicrobial resistance [14].
CC199 strains may also express the 15B/C capsule. Serogroup 15
isolates have recently increased in prevalence, albeit to a lesser
extent than serotype 19A [18], [19]. Serotype 19A is now included
in the expanded pneumococcal conjugate vaccine (PCV13), while
serotype 15B/C is not.
Differences in virulence have been reported between pneumo-
coccal serotypes [11], [20]–[22]. Furthermore, differences in
virulence within a serotype have been reported in animal models
[23] and population based studies [24]. Even closely related
isolates belonging to the same clone or sequence type (ST) can
differ in their capacity to cause disease [23].
The pneumococcal genome exhibits high plasticity and may be
categorized into the core genome, consisting of genes conserved
between all S. pneumoniae isolates, and the accessory genome,
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pneumoniae population [25]–[27]. Between 21–32% of genes in a
given strain belong to the accessory genome [26]. It has been
hypothesized that some genes may engender tissue-specific
advantages [23], [28], such as providing the isolate with an
increase in fitness or capacity to invade a given niche. In the
identification of tissue-specific genes, studies have often focussed
on established pneumococcal virulence factors or genes that are
differentially expressed in vivo [29]–[31]. Few studies have
examined the non-core component of the pneumococcal genome
to identify genes that provide a biological basis for tissue-
specificity. Comparative genome studies have focussed on invasive
disease rather than otitis media as a disease outcome [23], [27],
[32].
This study sought to evaluate genetic variation among CC199
isolates, and to identify genes associated with strains isolated from
a particular tissue source. CC199 isolates of the same genetic
background but different serotype (serotype 19A and 15B/C) were
compared in the chinchilla model of pneumococcal disease to
assess the relationship between genetic diversity and capsular
serotype on virulence. Importantly, this model allowed us to
ascertain virulence for otitis media. These strains also produced
bloodstream infection, permitting assessment of relative virulence
for invasive disease. The initial analysis of related isolates from the
same clonal complex reduced the genetic variation identified, and
consequently the level of noise encountered while identifying
tissue-associated genes among CC199. To gain additional insight
into S. pneumoniae tissue-associated genes, we identified genetic
regions associated with specific tissue sources among CC199
isolates and used these to screen a larger, genetically diverse
collection of pneumococcal isolates. We reasoned that if the
identified genes were truly important for tissue-specific virulence,
then they would also occur more frequently among diverse
pneumococcal sequence types and serotypes from these tissue sites.
Results
Genomic Diversity within Clonal Complex 199
Comparative genome hybridization (CGH) was used to evaluate
genetic diversity among nineteen CC199 isolates. One hundred
and twenty seven genes were found to be variable within CC199
(Table S1). The CGH results identified four regions of diversity
(RD), using the criteria specified by previous studies investigating
pneumococcal genomic diversity [23]. These included RD2, RD6,
and RD24 [23], and RD8 [27] (Table 1). The regions of diversity
differed from those previously described by Silva et al. RD2
identified within CC199 isolates did not contain SP0114 and
SP0115 and was approximately 0.7 kb smaller; RD24, identified
within CC199 isolates, was slightly larger due to the addition of
SP1947.
A phylogeny of the isolates was constructed by hierarchical
clustering based on the log2 ratio matrix (Figure 1). The phylogeny
obtained by hierarchical clustering closely agreed with the
dendrogram obtained by Dollo parsimony of the presence and
absence matrix (data not shown). CC199 splits into two main
clades, one of which consists of all but one of the disease isolates,
while the other comprises all but one of the carriage isolates
(Figure 1). The carriage clade is further split, based on serotype,
while the disease clade exhibits no additional structure based on
serotype.
Chinchilla Model of Pneumococcal Disease
We next sought to compare the virulence of carriage and disease
clade isolates in the chinchilla model of disease. Five representative
CC199 strains were selected for testing. In addition to a genome
sequenced reference 19A strain (CDC3059-06), one serotype 15B/
C and one serotype 19A isolate were selected from both the
carriage and invasive clades (Figure 1). None of the CC199 isolates
exhibited a significantly increased ability to colonize (Figure 2a) or
cause otitis media (Figure 2b). There was little difference between
serotype 19A and serotype 15B/C isolates’ ability to cause otitis
media (Figure 2b) or in the time taken for the isolate to cause
bacteremia (p=0.63).
While the isolates did not differ in their virulence potential by
serotype, isolates belonging to the disease clade of the CC199
phylogeny did exhibit a decreased duration of colonization before
causing bacteremia compared to carriage clade isolates (p=0.04).
Of the isolates from the disease clade, one serotype 19A isolate (06-
01-003 MEF) demonstrated an increased invasive virulence
potential beyond that of the other isolates, resulting in chinchilla
mortality within 48–72 hours, significantly more rapidly than
other disease isolates (p,0.0001).
Tissue-Specific Genes
The separation of the phylogeny of CC199 based predomi-
nantly on isolate tissue source (i.e. carriage vs. disease), combined
with the similar fitness of isolates by serotype, indicates that genetic
factors other than serotype impact on fitness for tissue-specific
Table 1. Regions of genetic diversity identified in clonal
complex 199 isolates.
Region of Genes Size* Encodes1
Diversity
2 SP0109 ,4.2 kb Putative Bacteriocin
- Putative Amino Acid ABC Transporters
SP0113 Hypothetical Protein
6 SP0394 ,5.3 kb Putative transcriptional regualtor
- Mannitol Phosphate Dehydrogenase
SP0397 Phophotransferase System
8 SP1315 ,31.5 kb Sodium ATP Synthase
- Oxidoreductase
SP1351 Putative neuraminidase
N-Acetylneuraminate Lyase
Putative N-Acetylmannosamine-6-P
Epimerase
Putative Phosphosugar-Binding
Transcriptional Regulator
Methyltransferase
Transposase
ABC Transporter/ATP Binding Protein
Drug Efflux ABC Transporter
Prolyl Oligopeptidase Family Protein
Putative Membrane Protein
Hypothetical Proteins
24 SP1947 ,9.0 kb Putative Bacteriocin Formation Protein
- Toxin Secretion ABC Transporter
SP1955 Serine Protease
Hypothetical Proteins
*Based on gene sizes taken from TIGR4 genome.
1Based on annotation taken from TIGR4 genome.
doi:10.1371/journal.pone.0018649.t001
Pneumococcal Diversity and Virulence of CC199
PLoS ONE | www.plosone.org 2 April 2011 | Volume 6 | Issue 4 | e18649virulence. The microarray analysis was not able to identify any
single genetic factor as being responsible for the difference
between the carriage and disease clades. Therefore, we sought to
identify non-core genes that might influence tissue-specific
virulence.
Correspondence analysis identified 11 genes as well as the
region of diversity RD8a as being associated with CC199 isolates
obtained from a particular tissue source. Next, we screened a
larger, genetically diverse collection of S. pneumoniae isolates
(n=326). Eight of the 11 genes were significantly associated with
a specific tissue source after screening of the larger collection. Two
of these genes encoded choline-binding proteins (cbpC and cbpJ),
which were negatively associated with invasive strains, compared
to carriage, as determined by PCR (OR [95% CI]): 0.46 [0.23,
0.90] and 0.33 [0.17, 0.61] for cbpC and cbpJ, respectively. These
findings could not be confirmed by hybridization due to the cross-
hybridization of the probe with other choline binding protein-
encoding genes in the genome.
Based on PCR, dot blot, and Southern hybridization screening,
seven genetic regions were found to be significant in their
association with either a particular tissue source, or with either
invasive or non-invasive isolates. The prevalence data for the seven
genetic regions within CC199 are in Table 2. It should be noted
that correspondence analysis does not provide a statistical test of
the strength of the association and a limited number of CC199
strains were examined. Among the larger collection of S. pneumoniae
isolates, the prevalence ranged from 29% (RD8 in carriage
isolates) to 81% (SP1793 in CSF isolates) (Table 2). The odds
ratios and 95% CI for each genetic region by tissue source are
presented in Table 3. SPN05002, which encodes a hypothetical
protein, was present significantly more frequently in strains
isolated from middle ear fluid, blood, and CSF than from those
strains isolated from carriage. The genetic region RD8a was also
present significantly more frequently in strains isolated from
middle ear fluid and blood than carriage. Conversely, spr0282,
which encodes a phosphotransferase system sugar-specific EII
component, was present significantly more frequently in strains
isolated from carriage than from middle ear fluid or blood.
Hypervirulent Isolate
As described above, one isolate 06-01-003MEF (CC199, 19A)
was found to have an increased invasive virulence potential in the
chinchilla model. No single genetic variation could be found by
microarray to explain the increased virulence observed for the
serotype 19A isolate. While current microarray slides comprise
probes for genes from several completely sequenced genomes, the
high degree of plasticity in S. pneumoniae genomes is such that
microarrays will not possess the full complement of probes for a
given isolate being tested. Therefore, a comparison was made of
the genome sequences of the hypervirulent isolate and the isolate
CDC3059-06 (CC199, 19A), which was representative of the
virulence potential of the CC199 isolates in this study.
The genome of the hypervirulent isolate 06-01-003MEF was
found to contain approximately 35 kb of genetic material not
possessed by the reference isolate CDC3059-06, while CDC3059-
06 contained approximately 42 kb of sequence not found in the
genome of 06-01-003MEF. The three remaining CC199 isolates
tested in the chinchilla model of pneumococcal disease were
screened for the presence or absence of these genetic regions, both
by PCR and by examining the microarray data. A single genetic
Figure 1. Hierarchical clustering dendrogram of clonal complex 199 isolates. *Strain tested in the chinchilla model of disease Coloured
column one relates to tissue source. Red=carriage, Blue=Middle ear fluid, Green=Blood, Purple=Cerebrospinal fluid, Orange=Pleural Fluid.
Coloured column two relates to serotype. Bright blue=3, Brown=15B/C, Pink=19A.
doi:10.1371/journal.pone.0018649.g001
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A. Bacterial counts from nasopharyngeal washes obtained on day 1. B. Bacterial counts from middle ear fluid samples obtained on day 8.
doi:10.1371/journal.pone.0018649.g002
Table 2. Distribution of putative tissue-specific genes among S. pneumoniae isolate collections.
No. of isolates positive for given gene (%)
Collection SP0163 SP0395 SP0463 SP1793 SPN05002 spr0282 RD8a
CC199
Carriage (n=7) 6 (86) 3 (43) 2 (29) 3 (43) 4 (57) 0 (0) 7 (100)
Middle Ear (n=5 ) 3 (60) 2 (40) 3 (60) 3 (60) 1 (20) 0 (0) 1 (20)
Blood (n=5) 4 (80) 1 (20) 3 (60) 4 (80) 2 (40) 1 (20) 2 (40)
Larger Collection
Carriage (n=92) 45 (49) 59 (64) 35 (38) 56 (61) 31 (34) 66 (72) 27 (29)
Middle Ear (n=94) 68 (72) 43 (46) 58 (62) 53 (56) 60 (64) 50 (53) 48 (51)
Blood (n=83) 44 (53) 56 (67) 39 (47) 52 (63) 60 (72) 46 (55) 41 (49)
CSF (n=57) 27 (47) 44 (77) 19 (33) 46 (81) 44 (77) 34 (60) 25 (44)
Total (n=326) 184 (56) 202 (62) 151 (46) 207 (63) 195 (60) 196 (60) 141 (43)
*RD8 was present in the CSF isolate. SP0163, SP0395, spr0282, and RD8a were present in the pleural fluid isolate.
doi:10.1371/journal.pone.0018649.t002
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the hypervirulent isolate 06-01-003MEF, but absent in CDC3059-
06 and all three of the other isolates tested in the chinchilla model
of pneumococcal disease. The region comprised at least 25
predicted genes, with ,65% of the sequence comprising coding
sequence and a GC content of ,39%. When queried against the
NCBI BLAST database, 14 of the 25 predicted genes were of
unknown function, while the remainder corresponded to bacte-
riophage structural genes.
Discussion
The data presented in this study supports previous research that
has identified S. pneumoniae as a genetically highly heterogeneous
species, even within closely related strains [23], [26]. The ability to
colonize and cause disease did not differ depending on the isolate’s
serotype when tested in the chinchilla model. However, isolates in
the disease clade were associated with a decreased time to cause
bacteremia compared to isolates in the carriage clade. One
hypervirulent serotype 19A isolate was associated with a short time
to bacteremia and high mortality. The genome of this strain
contains a 20 kb genetic region that is absent in the other CC199
isolates tested in the chinchilla. This hypervirulent strain may have
acquired a bacteriophage with novel virulence factors, although
further analysis is required to identify the precise role of this
sequence, if any, in the observed hypervirulence of isolate 06-01-
003MEF. Taken together, these data indicate that genetic factors,
other than capsule polysaccharide, modulate virulence potential in
CC199. Serotype 15B/C is not included in PCV13 [32]. Given
the similar genetic background and similar pathogenicity in the
chinchilla, CC199 strains of serotype 15B/C may increasingly
cause acute otitis media in children.
We hypothesize that CC199 strains are successful at the
population level because they are a generalist lineage adept at
carriage, otitis media, and invasive disease. Within CC199, isolates
of both serotype 15B/C and 19A were equally able to colonize and
cause otitis media in the chinchilla model. Furthermore, there was
little difference in the time taken to cause invasive disease by
serotype. These data expand upon a previous study that indicated
similar fitness for otitis media when serotype 19A and 15B/C
isolates were inoculated together in competition [34]. While
isolates belonging to the carriage clade have the potential to cause
disease, isolates from the disease clade were associated with faster
development of invasive disease. It remains to be seen if the
identified pattern of separate carriage and disease clades in CC199
is repeated for other established clones, such as CC156 or CC176.
This study has identified genes of potential importance in tissue-
specific virulence, which will require additional study to assess
their potential and function as virulence factors. A larger collection
more representative of the pneumococcal population was screened
to determine whether those associations identified in CC199
isolates would be maintained in a more genetically diverse
collection. Given that S. pneumoniae is a highly recombinogenic
species, tissue-specific associations that are preserved throughout
the population as a whole would be expected to be of biological
importance to the species. However, it is worth noting that for two
of the genetic loci, spr0282 and RD8a, the tissue-specific
associations differed in the overall pneumococcal population when
compared to the CC199 data, although no statistical significance
was given to the CC199 data due to small sample size. This would
seem to indicate that the effect of a gene may be dependent on the
combination of genes found in the remainder of the pneumococcal
genome.
Previous studies have identified individual genes associated with
otitis media, pneumonia, and meningitis [31], [35]–[37]. We
identified RD8a as more common among our middle ear and
blood isolates in comparison to carriage. Obert et al previously
described the correlation between the region of diversity RD8a
and invasive isolates [27]. SP0463 (rrgB) is on the pilus locus [38]
and has previously been identified in a minority of invasive
pneumococcal isolates [39]. Our finding that SP0463 is found
significantly more often in middle ear isolates than carriage isolates
seems at variance with other data that pneumococcal isolates do
not contain genes encoding pili at a greater frequency in otitis
media isolates than in invasive disease isolates [40]. It is likely that
the disparity arises through the specific isolate collections
examined or the difference in target genes used by each study.
Moschioni et al [40] targeted entire pilus encoding islets, this study
focussed on a single gene within the islet.
The specific combination of putative tissue-specific genes
differed for each of the isolates tested in the chinchilla model.
Furthermore, we did not identify a single genetic factor from the
accessory genome, present in all strains from a specific tissue
source. A supragenome pool exists for S. pneumoniae, which consists
of the total number of genes available to the species [26], [41],
[42]. A given gene may associate with S. pneumoniae isolates from a
specific tissue-source. Furthermore, a given gene may enhance
fitness for tissue-specific disease, yet an isolate lacking this gene can
still cause disease. These data may be explained by high levels of
recombination and functional redundancy amongst the accessory
regions within the pneumococcal genome. Blomberg et al did not
identify a unique pattern of accessory regions among invasive
Table 3. Adjusted odds ratios for each of the tissue-specific genes identified by correspondence analysis.
Locus Product Odds Ratios
Middle ear vs
Carriage Blood vs Carriage CSF vs Carriage Disease vs Carriage Invasive vs Non
SP0163 Transcriptional Regulator 2.73 (1.48, 5.02) 1.18 (0.65, 2.13) 0.94 (0.48, 1.82) 1.53 (0.94, 2.48) 0.66 (0.43, 1.04)
SP0395 Transcriptional Regulator 0.45 (0.25, 0.82) 1.23 (0.65, 2.30) 1.89 (0.89, 4.01) 0.88 (0.53, 1.44) 2.18 (1.37, 3.49)
SP0463
SP1793
Cell Wall Surface Anchor Protein
Hypothetical Protein
2.49 (1.38, 4.47)
0.83 (0.46, 1.49)
1.44 (0.79, 2.64)
1.08 (0.59, 1.99)
0.81 (0.41, 1.63)
2.69 (1.23, 5.86)
1.57 (0.96, 2.58)
1.24 (0.76, 2.05)
0.72 (0.46, 1.12)
1.65 (1.04, 2.62)
SPN05002 Hypothetical Protein 3.13 (1.72, 5.67) 4.89 (2.57, 9.32) 6.35 (2.99, 13.47) 4.27 (2.56, 7.12) 3.01 (1.88, 4.85)
spr0282 Phosphotransferase System 0.43 (0.23, 0.78) 0.49 (0.26, 0.92) 0.58 (0.29, 1.17) 0.48 (0.29, 0.81) 0.51 (0.33, 0.79)
RD8a Region of Diversity 2.41 (1.32, 4.39) 2.35 (1.26, 4.38) 1.88 (0.94, 3.75) 2.25 (1.34, 3.77) 1.34 (0.86, 2.09)
Odds ratios in bold indicate those that were significant.
doi:10.1371/journal.pone.0018649.t003
Pneumococcal Diversity and Virulence of CC199
PLoS ONE | www.plosone.org 5 April 2011 | Volume 6 | Issue 4 | e18649disease isolates and concluded that redundancy existed amongst
the accessory regions required to cause invasive pneumococcal
disease [32]. Our data indicate that this redundancy holds for otitis
media as well as invasive disease.
One hypervirulent CC199 19A (06-01-003 MEF) strain caused
rapid mortality. The bacteriophage sequence within this region
may encode virulence determinants. A majority of S. pneumoniae
strains contain lysogenic phage [43], [44]. Researchers have
speculated that phage-encoded proteins modulate S. pneumoniae
fitness [45]. Further analysis of this sequence is required to identify
if this is indeed the basis for the differences in virulence observed
between the isolates.
This study had limitations. Genomic diversity of CC199 was
evaluated using CGH. As mentioned previously, microarrays are
limited in that genetic regions that are not included on the array
will be missed. Genes that are highly variable in sequence may also
fail to hybridize and will be counted as absent. Additional
unmeasured factors, such as level of capsule expression, may also
contribute to differences in virulence. As with any animal model,
our data may not be fully reflective of S. pneumoniae carriage and
disease in humans. A small number of chinchillas were used in
each experiment and the chinchilla model does not use a
genetically pure line. However, the advantage to the chinchilla
model is it closely mirrors pneumococcal disease aetiology where
colonization is established before disease.
In summary, the approval of PCV13 by the FDA in 2010 [33]
means that isolates belonging to serotype 19A should be protected
against in the future. However, this expanded vaccine does not
include protection against serotype 15B/C. Recent studies have
indicated an increase in the prevalence of serogroup 15 isolates
amongst carriage and otitis media [10], [18]. Small but significant
increases in the proportion of serotype 15B/C isolates have been
observed among invasive disease cases [7]. While immunization
with PCV13 is likely to result in disease reduction, the similarities
in terms of virulence between 19A and 15B/C isolates suggest that
a vaccine based on genetic factors other than serotype is necessary,
especially for otitis media and nonbacteremic pneumonia. Such
genetic factors could belong to the core genome or comprise
several from the accessory genome, which together cover the
entire pneumococcal population. Alternatively, future vaccines
could be targeted towards tissue-specific genes, allowing physicians
to protect patients from invasive pneumococcal disease, while not
affecting those pneumococcal isolates that exist among carriage
isolates in the nasopharynx [46].
Materials and Methods
Ethics Statement
The Institutional Animal Care and Use Committee at Boston
University Medical Center approved our animal care protocols as
being consistent with humane treatment of laboratory animals
and with standards set forth in the Guide for the Care and Use of
Laboratory Animals and the Animal Welfare Act (Animal
Welfare Assurance approval number A-3316-01). Thus, our
study was carried out in strict accordance with the recommen-
dations in the Guide for the Care and Use of Laboratory Animals
of the National Institutes of Health. All efforts were made to
minimize suffering. Procedures to obtain nasopharyngeal lavages,
middle ear cultures and phlebotomy were performed under
Ketamine and Xylazine anaesthesia. All animals were examined
daily for activity levels, fluid intake, and temperature. Early
euthanasia was used when labyrinthitis was present or when
animals exhibited a decrease in weight greater than 10%.
Animals were euthanized using CO2.
Bacterial Isolates, Growth Conditions, and DNA Extraction
A collection of 20 S. pneumoniae isolates was selected for analysis
by CGH. Nineteen CC199 isolates were selected from collections
previously analyzed by multilocus sequence typing (MLST) [28],
[47]. Isolates were obtained from a variety of tissue sources,
including the nasopharynx or throat (n=7), middle ear fluid
(n=5), blood (n=5), cerebrospinal fluid (CSF) (n=1), and pleural
fluid (n=1). CC199 isolates were serotype 19A (n=7) or 15B/C
(n=12). A serotype 3 isolate (ST180) was included as an outgroup
for phylogeny construction. All isolates were obtained from the
United States. With only two exceptions, strains were isolated
since 2000 (isolates ME2815 and ME3582 were isolated in 1996).
Isolate 3059-06 came from a patient 47 years of age and isolate
03AR0753 came from a patient of unknown age. The remaining
isolates were from patients less than 48 months of age. Isolates to
be analyzed by CGH were grown overnight in Todd Hewitt, 5%
yeast extract at 37uC with 5% CO2. DNA was extracted using
QIAGEN 100/G genomic tips.
A larger genetically diverse collection of S. pneumoniae isolates
[28], was screened to ascertain the prevalence of genes associated
with CC199 isolates from a given tissue source. This genetically
diverse collection was comprised of nasopharyngeal or throat
isolates from healthy children (collectively analyzed as the
‘‘carriage group’’) (n=92), middle ear (n=94), blood (n=83),
and cerebrospinal fluid (n=57). S. pneumoniae strains represented a
range of serotypes and sequence types. DNA extractions for
isolates to be screened by PCR involved overnight growth on
trypticase soy agar plates with 5% sheep blood and inoculation of
a colony into a 96-well plate containing 50 ml of Tris-EDTA buffer
followed by boiling for 10 min.
DNA Labelling and Microarray Hybridization
DNA was labelled using a BioPrimeH Plus Array CGH Indirect
Genomic Labelling System (Invitrogen). DNA labelling and
microarray hybridization was conducted by staff at the W.M.
Keck Facility at Yale.
Microarray Analysis
TM4: Microarray Software Suite (TIGR) [48] and SAS v9.1
(SAS Institute, Cary, NC) were used in data analyses. LOWESS
(locally weighted scatterplot smoothing) was used to normalize raw
data in a single experiment, with 50% of the data being used for
smoothing. The LOWESS normalization was used as part of a
pipeline in MIDAS, which includes total intensity normalization,
LOWESS normalization, standard deviation regularization and
low intensity filtering [48]. Hybridization spots with a signal to
noise ratio of less than 2.0 were removed from further analysis.
PartekH Genomics Suite
TM 6.4 (Partek Inc., St. Louis, MO) was
used to remove variation in the data due to batch effects.
Two different methods were applied to the microarray data to
determine if a given gene was present or absent. The program
GACK was used to convert the data from each microarray
experiment to present or absent [49]. Alternatively, arbitrary
cutoff values were selected. Hybridization spots with a log2 ratio
above 1, 1.5, 2 or 2.5 were denoted as present, while those with a
ratio below 21, 21.5, 22o r22.5 were identified as absent. A
range of cut-off value combinations were assessed.
Hierarchical clustering of the log2 ratio matrix, and visualization
of the resulting dendrogram, was performed in PartekH Genomics
Suite
TM 6.4, using Pearson’s Dissimilarity to calculate row
dissimilarity and Ward’s method for row clustering. A phylogeny
of the isolates was also constructed using Dollo parsimony based
on the presence and absence matrix of genes [50] implemented in
PAUP4.0b10. Hybridization spots that produced missing data for
Pneumococcal Diversity and Virulence of CC199
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construction. Both dendrograms were rooted with a serotype 3,
ST180 isolate.
All CGH data generated by this study were fully annotated and
deposited at the Gene Expression Omnibus (GEO; Accession
numbers GSM591013–GSM591034). Data uploaded to the GEO
database is MIAME compliant, representing the final data from
the normalisation pipeline. Subsequent data generated via batch
effect removal could not be uploaded due to file formatting issues,
but is available upon request.
PCR Validation of Microarray Results
Eighteen genes, including both core and variable genes, were
chosen to validate CGH results. Primer sequences were designed
for each gene (Table S2). PCR involved an initial denaturation
step of 95uC for 3 min; 35 cycles of 95uC for 30 sec, the relevant
annealing temperature for 30 sec (Table S2), and 72uC for 30 sec;
and a final extension of 72uC for 10 min.
Chinchilla Model of Pneumococcal Disease
Five pneumococcal isolates were tested in the chinchilla model
of pneumococcal disease. Female chinchillas (Chinchilla laniger) with
no prior evidence of middle ear infection were used. One serotype
15B/C and one serotype 19A isolate were selected from each clade
of the CC199 phylogeny. Isolates MIB02102 and MIC17101 were
serotype 15B/C, and 06-01-003MEF and FG23 were serotype
19A, from the invasive and carriage clades, respectively. A genome
sequenced reference strain (isolate CDC3059-06, serotype 19A)
was also included.
Isolates were grown as monocultures and used to inoculate the
left nare of two to eight healthy chinchillas [34], [51]. The S.
pneumoniae strains were allowed to establish nasopharyngeal
colonization. Nasopharyngeal washes were collected from all
animals on day 1 and day 5 by lavage with Hanks buffer.
Barotrauma, which creates negative pressure in the middle ear
cavity by aspiration of up to 250 ml of air with a 25-guage needle,
was performed unilaterally on day 5 to prompt development of
otitis media. Chinchillas were monitored daily by otomicroscopy
and tympanometry. Once the animal developed signs of otitis
media, the middle ear cavity was accessed through a small hole in
the bullar bone. Nasopharyngeal and middle ear samples were
collected for quantitative microbiology. Total viable counts (CFU/
ml) were obtained by plating on blood agar and incubation at
37uC overnight. Total viable counts were calculated from day 1,
representing the initial colonization phase, and day 8, the first
middle ear fluid sample obtained.
Differencesinthetotalviablecountsforeachisolate weretestedfor
by one-way analysis of covariance (ANCOVA), with Tukey,
Bonferroni and Duncan post-tests being used for multiple compar-
isons. Weight of the individual chinchilla and the inoculation
bacterial load were controlled for during these tests. The assumption
of normality was not met. However non-parametric and parametric
bivariate analyses provided similar results, suggesting the ANCOVA
is robust enough to handle the violation of assumptions, and also
allow us to control for weight and inoculation load. An isolate’s
propensity to cause invasive disease was determined through the
length of time between colonization and the development of
bacteremia. Differences in the time to bacteremia were tested using
survival analysis (Kaplan-Meier survival curves, and log rank tests).
The assumption of proportionality was met.
Identification of Tissue-Specific Genes
Correspondence analysis was implemented in SAS v9.1 (SAS
Institute, Cary, NC) to narrow the list of genes associated with
isolates obtained from a particular tissue source (carriage, middle
ear, or blood isolates). CSF and pleural fluid isolates were not
included due to low numbers. For any given gene, its frequency
amongst the isolates obtained from each tissue source was
calculated, and used for each comparison. Correspondence
analysis does not provide a measure of significance. Therefore
the list of genes was verified and narrowed further by removal of
genes that were equally present between tissue sources.
The larger isolate collection [29] was screened by PCR to
ascertain the prevalence of genes identified as associated with a
particular tissue source by correspondence analysis. Primers are
detailed in Table S3. With the exception of primers to amplify
cbpG [52], all primers were designed within this study. PCR
involved an initial denaturation step of 95uC for 3 min; 35 cycles
of 95uC for 30 sec, the relevant annealing temperature for 30 sec
(Table S3), and 72uC for 30 sec; and a final extension of 72uCf o r
10 min. The presence or absence of each gene was confirmed for
PCR-negative isolates by dot blot and Southern hybridization,
using previously described methods [28]. Briefly, PCR amplifi-
cation of TIGR4 genomic DNA was used to generate a gene-
specific probe, using the gene-specific primer pairs listed in Table
S3. The Gene Images AlkPhos Direct Labeling and ECF
chemifluorescence detection system (Amersham Biosciences,
Piscataway, N.J.) was used for labelling, hybridization, washes,
and signal detection.
Tissue-Specific Gene Analysis
Statistical analyses were carried out using SAS version 9.1 (SAS
Institute, Cary, NC). The distribution of S. pneumoniae STs, clonal
groups, and tissue-specific genes in the isolate collection were
described using simple descriptive statistics. Logistic regression was
used to calculate odds ratios and 95% confidence intervals for each
gene for the isolate populations of each tissue source versus the
carriage population. In addition, statistics were calculated for
disease (middle ear, blood, and CSF) versus carriage populations
as well as invasive (blood and CSF) versus non-invasive (carriage
and middle ear) isolate populations.
Complete Genome Sequencing
The chromosomal DNA of isolate 06-01-003MEF (CC199,
serotype 19A) was sequenced using the Solexa paired-end
sequencing platform (Illumina, San Diego, CA). Seventy-five bp
reads were generated, resulting in an on average coverage of 16X.
The paired-end sequences were trimmed based on quality score by
bTrim (Kong, unpublished, http://graphics.med.yale.edu/trim/
readme). Sequences that passed trimming were assembled by
Velvet [53]. Different parameters of bTrim and Velvet were
evaluated to optimize the final contigs with respect to n50 and the
greatest contig length. This Whole Genome Shotgun project has
been deposited at DDBJ/EMBL/GenBank under the accession
AEGF00000000. The version described in this paper is the first
version, AEGF01000000.
The genome sequence of 06-01-003MEF was compared to the
publicly available genome of isolate CDC3059-06 (CC199,
serotype 19A) (accession number NZ_ABGG00000000). Sequenc-
es unique to each genome were identified via subtractive BLAST
analysis on the assembled sequence data sets. Sequences found to
have a matching sequence in the corresponding genome were
removed from both genomes. Genes were subsequently identified
in the remaining unique sequences using Glimmer3 [54].
Sequence similarity with publicly available sequences was assessed
using the NCBI BLAST database (http://www.ncbi.nlm.nih.gov/
BLAST).
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